SEC Form 3 · accession 0002142262-26-000004
Attovia Therapeutics, Inc. · ATTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hubert Chen
Officer — Chief Medical Officer
Period of report
Aug 4, 2026
Accepted (ET)
Aug 4, 2026 · 7:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002058707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,960 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.5302 | holding | — | — | — | — | May 8, 2034 | Common Stock | 115,446 | — | D |
| Stock Option (Right to Buy)F2 | $3.5302 | holding | — | — | — | — | May 8, 2034 | Common Stock | 96,878 | — | D |
| Stock Option (Right to Buy)F3 | $4.9237 | holding | — | — | — | — | May 17, 2035 | Common Stock | 80,731 | — | D |
Explanation of responses
- F1The option vests over a four-year period. The vesting schedule is as follows: 25% of the shares of common stock underlying the stock option vested on March 20, 2025, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service to the Issuer through such date.
- F2The option vests over a four-year period. The vesting schedule is as follows: 25% of the shares of common stock underlying the stock option vested on May 9, 2025, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service to the Issuer through such date.
- F3The option vests over a four-year period. The vesting schedule is as follows: 25% of the shares of common stock underlying the stock option vested on May 18, 2026, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service to the Issuer through such date.